近日,由中国中药协会呼吸病药物研究专业委员会研制的《中西医联合防治肺结节临床应用专家共识(2025版)》发布,该共识由张伯礼等权威专家领衔,是我国首部聚焦肺结节中西医协同防治的专家共识。广药集团白云山盈康独家品种黄根片被纳入推荐用药,为肺结节中医药干预提供新方案。当前肺结节检出率攀升,西医缺乏有效干预药物,临床对安全有效的防治手段需求迫切。黄根片作为国内首个获批用于矽肺治疗的壮药单方制剂,与肺...
Source Link近日,由中国中药协会呼吸病药物研究专业委员会研制的《中西医联合防治肺结节临床应用专家共识(2025版)》发布,该共识由张伯礼等权威专家领衔,是我国首部聚焦肺结节中西医协同防治的专家共识。广药集团白云山盈康独家品种黄根片被纳入推荐用药,为肺结节中医药干预提供新方案。当前肺结节检出率攀升,西医缺乏有效干预药物,临床对安全有效的防治手段需求迫切。黄根片作为国内首个获批用于矽肺治疗的壮药单方制剂,与肺...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.